Recombinant PCSK9 (Ralpancizumab Biosimilar) antibody

Catalog No. ABIN7676065

The Human Monoclonal anti-PCSK9 (Ralpancizumab Biosimilar) antibody is suitable to detect PCSK9 (Ralpancizumab Biosimilar) in samples from Human. It has been validated for BLI, ELISA, FACS, Func and SPR.

Quick Overview for Recombinant PCSK9 (Ralpancizumab Biosimilar) antibody (ABIN7676065)

Target: PCSK9 (Ralpancizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This PCSK9 (Ralpancizumab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-PCSK9 (Ralpancizumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-PCSK9 Reference Antibody (ralpancizumab)

Characteristics: Anti-PCSK9 Reference Antibody (ralpancizumab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG2SA

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for PCSK9 (Ralpancizumab Biosimilar)

Target: PCSK9 (Ralpancizumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: Q8NBP7